Brief: Protara Therapeutics Q3 Loss Per Share Of $0.96
04/11/2021 12:53
Nov 4 (Reuters) - Protara Therapeutics Inc TARA.O :
* Q3 LOSS PER SHARE $0.96
* QTRLY CASH, CASH EQUIVALENTS AND MARKETABLE DEBT
SECURITIES
TOTALED $138.4 MILLION
Source text for Eikon: ID:nGNX9bvWHL
Further company coverage: TARA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses